In the House of Lords Grand Committee debate on cancer outcomes, our breath test was cited by the Baroness Warwick of Undercliffe as an example of an innovative diagnostic test that could help GPs triage patients with vague symptoms, with results potentially available within three days.
George Hanna has been elected as a Senior Investigator of the National Institute for Health and Care Research (NIHR), in recognition of his contribution to the NIHR, research inclusion, equality, diversity and inclusion, and leadership and capacity building.
We welcomed Stuart Andrew MP, Shadow Secretary of State for Health and Social Care, to The Hanna Group. The visit included a tour of our VOC laboratory and an overview of our research programme and ongoing clinical trials.
February is Oesophageal Cancer Awareness Month. Oesophageal cancer is one of the top five cancers worldwide — around 9,000 people are diagnosed in the UK each year. Our research focuses on developing non-invasive breath tests to detect cancer early by identifying unique volatile compounds present in higher numbers in the…
In the Commons debate on less survivable cancers 2026, the breath test was described by Paulette Hamilton MP as “transformative” and Steff Aquarone MP as “a real game changer”
Find out how a simple, painless breath test is using machine learning to sniff out the disease in its earliest stages, and why it could transform cancer screening forever.
Professor George Hanna has officially been elected as a Fellow of the EACS. This prestigious recognition highlights his exceptional contributions to surgical oncology and his relentless drive to revolutionise diagnostics.
The multiple media outlets highlighted our recent advancements in clinical screening for pancreatic cancer, showcasing the potential of our breath test to transform diagnostics.
A huge congratulations to Nayaab N A Kader and Henry D P Robb for finishing the London Marathon and raising money for Pancreatic Cancer UK. Nayaab also had the chance to discuss our breath test for early diagnosis of pancreatic cancer with Gabby Logan on the BBC.
Henry D P Robb and Nayaab N A Kader attended the Shoes of Hope event ahead of representing Pancreatic Cancer UK at the London Marathon. The event displays 797 pairs of shoes, representing the number of lives lost every month to pancreatic cancer in the UK.
We held an event with our community partner Reviving Links to help set up an EDI advocacy group at Imperial College London, with productive discussions about barriers to recruitment in research and ways of creating a more inclusive research environment.
Professor George Hanna and team hosted the NIHR HealthTech Research Centre in In Vitro Diagnostics (HRC IVD) launch event, presenting the centre's exciting research that will support the development and adoption of diagnostics in healthcare.
Mohamed Abulazayem has sampled the first participant of the HOPE study at Hammersmith Hospital and Meadows Centre for Health — a key milestone for the trial.
The PANACEA team was invited to present at the 'Innovation in the early diagnosis of cancer' event at the BMA House, London, hosted by NHS Cancer Programme.
In the House of Lords debate on the National Cancer Plan 2025, Lord Kamall cited our breath test and asked how Government and NHS processes could accelerate the roll-out of relatively low-cost innovations.
The VAPOR team joined Pancreatic Cancer UK at the Association of Medical Research Charities showcasing event at the House of Commons, discussing the urgent need for earlier detection in pancreatic cancer with ministers and MPs, and demonstrating our breath test in action.
VOC laboratory was also selected by the UK Committee on Research Integrity as a case study for adopting industry standards to increase efficiency and rigour in academic laboratory environments.
Ms Whately met Professor George Hanna, Head of the Department of Surgery and Cancer, Professor Jonathan Weber, Dean of the Faculty of Medicine, and representatives from the charity Pancreatic Cancer UK to see Professor Hanna’s work on developing breath tests to detect cancer earlier.
Professor Hanna has been recognized for his outstanding contributions to biomedical research. Recognised alongside 60 of the influential people in biomedical and health research, this election cements his impact on the future of healthcare.
